US Patent Issued to Suzhou Kanova Biopharmaceutical, Beijing Kanova Biopharmaceutical on March 25 for "Anti-IL-25 antibodies and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,392, issued on March 25, was assigned to Suzhou Kanova Biopharmaceutical Co. Ltd. (Jiangsu, China) and Beijing Kanova Biopharmaceutical Co. Ltd. (Beijing).

"Anti-IL-25 antibodies and use thereof" was invented by Li Guo (Beijing), Tiantian Sun (Beijing), Xiaoxu Qi (Beijing) and Chen Dong (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides anti-IL-25 antibodies that are directed against (human) IL-25, nucleic acids that encode such antibodies, compositions, and in particular pharmaceutical compositions that comprise such antibodies; and uses of such antibodies and compositions."

The patent was filed on Nov. 19, 201...